Please assess the completion status of the following clinical trial:

Trial Title: Cerebral and Peripheral Perfusion Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult (ages 40-65) children of parent with documented Alzheimer's disease~Exclusion Criteria:~* Current use of cholesterol lowering medication~* History of liver disease~* History of adverse reaction to statin medications~* Elevated lab values (CK and creatinine)~* Use of medications that counteract with atorvastatin~* History of dementia~* Currently pregnant~* Use of large quantities of grapefruit juice (more than 1 quart/day)~* Current involvement in another investigational drug study~* Contraindications to MRI

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Atorvastatin (Type: EXPERIMENTAL): 40mg Atorvastatin nightly for 4 months
- Placebo (Type: PLACEBO_COMPARATOR): matching placebo nightly for 4 months

Based on this trial design, predict the completion outcome and termination type (if applicable).